Article
Analysis of the relationship between the Pro12Ala variant in the PPAR-gamma2 gene and the response rate to therapy with pioglitazone in patients with type 2 diabetes.
Diabetes care - 1 Mar 2003
Blüher Matthias, Lübben Georg, Paschke Ralf
Abstract excerpt
OBJECTIVE: To investigate the influence of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) gene variants on the response rate to therapy with the thiazolidinedione (TZD) pioglitazone, because in vitro studies have suggested that genetic variants of the PPAR-gamma gene may influence...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
